Gene · 642
Papers2,639
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 2,639
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Innate immune biology in age-related macular degeneration. | Front Cell Dev Biol | 2023 | 36926522 | PubTator, text mining | PubMed |
| Rab32 promotes glioblastoma migration and invasion via regulation of ERK/Drp1-mediated mitochondrial fission. | Cell Death Dis | 2023 | 36922509 | PubTator, text mining | PubMed |
| Household structure, composition and child mortality in the unfolding antiretroviral therapy era in rural South Africa: comparative evidence from population surveillance, 2000-2015. | BMJ Open | 2023 | 36921956 | PubTator, text mining | PubMed |
| Dynamic variations in COVID-19 with the SARS-CoV-2 Omicron variant in Kazakhstan and Pakistan. | Infect Dis Poverty | 2023 | 36918974 | PubTator, text mining | PubMed |
| TNIP1 inhibits selective autophagy via bipartite interaction with LC3/GABARAP and TAX1BP1. | Mol Cell | 2023 | 36898370 | PubTator, text mining | PubMed |
| Shaping the future from the small scale: dry powder inhalation of CRISPR-Cas9 lipid nanoparticles for the treatment of lung diseases. | Expert Opin Drug Deliv | 2023 | 36896650 | PubTator, text mining | PubMed |
| The luminescent and reaction mechanisms of a fluorescent probe for the detection of hypochlorous acid: Insights from theory. | Spectrochim Acta A Mol Biomol Spectrosc | 2023 | 36889138 | PubTator, text mining | PubMed |
| Study of NAD-interacting proteins highlights the extent of NAD regulatory roles in the cell and its potential as a therapeutic target. | J Integr Bioinform | 2023 | 36880517 | PubTator, text mining | PubMed |
| CT hyperdense cerebral artery sign reflects distinct proteomic composition in acute ischemic stroke thrombus. | J Neurointerv Surg | 2023 | 36878687 | PubTator, text mining | PubMed |
| Effects of occupational exposures on respiratory health in steel factory workers. | Front Public Health | 2023 | 36866091 | PubTator, text mining | PubMed |
| Economic evaluations of interventional opportunities for the management of mental-physical multimorbidity: a systematic review. | BMJ Open | 2023 | 36854591 | PubTator, text mining | PubMed |
| Natural course and risk factors of moyamoya disease with unruptured intracranial aneurysm. | Front Neurol | 2023 | 36846147 | PubTator, text mining | PubMed |
| The plasma virome in longitudinal samples from pregnant patients. | Front Cell Infect Microbiol | 2023 | 36844406 | PubTator, text mining | PubMed |
| Protective Barriers Provided by the Epidermis. | Int J Mol Sci | 2023 | 36834554 | PubTator, text mining | PubMed |
| Extracellular Vesicles as Potential Biomarkers in Amyotrophic Lateral Sclerosis. | Genes (Basel) | 2023 | 36833252 | PubTator, text mining | PubMed |
| The Many (Inter)faces of Anti-CRISPRs: Modulation of CRISPR-Cas Structure and Dynamics by Mechanistically Diverse Inhibitors. | Biomolecules | 2023 | 36830633 | PubTator, text mining | PubMed |
| DIMPLE: deep insertion, deletion, and missense mutation libraries for exploring protein variation in evolution, disease, and biology. | Genome Biol | 2023 | 36829241 | PubTator, text mining | PubMed |
| Machine learning analysis of complex late gadolinium enhancement patterns to improve risk prediction of major arrhythmic events. | Front Cardiovasc Med | 2023 | 36824460 | PubTator, text mining | PubMed |
| COVID-19 induced changes in physical activity patterns, screen time and sleep among Swedish adolescents - a cohort study. | BMC Public Health | 2023 | 36823595 | PubTator, text mining | PubMed |
| The clinical course of untreated CIN2 (HPV16/18+) under active monitoring: A protocol of systematic reviews and meta-analysis. | Medicine (Baltimore) | 2023 | 36820536 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/642/papers?page=15